• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    InDex Pharmaceuticals discontinues cobitolimod phase III program

    22 Nov 2023 //

    PR NEWSWIRE

    InDex Pharmaceuticals announces that all patients needed for the cobitolimod dose selection milestone have completed Induction Study 1 of the phase III program CONCLUDE

    11 Oct 2023 //

    PR NEWSWIRE

    Positive results from PK study with cobitolimod` selected as one of the best abstracts for presentation

    22 Aug 2023 //

    PR NEWSWIRE

    InDex Pharma has been granted a new patent in Europe for cobitolimod

    02 Aug 2023 //

    PR NEWSWIRE

    InDex announces positive results from PK study with cobitolimod

    15 Mar 2023 //

    PR NEWSWIRE

    InDex updates the timeline of the phase III study CONCLUDE with cobitolimod

    27 Jan 2023 //

    PR NEWSWIRE

    InDex Pharma successfully interacts with PMDA for cobitolimod in Japan

    16 Aug 2022 //

    PRNEWSWIRE

    InDex Pharmaceuticals gets new patent for cobitolimod granted in Europe

    13 Jul 2022 //

    PRNEWSWIRE

    InDex Pharmaceuticals prepares for commercialisation of cobitolimod

    14 Mar 2022 //

    PRNEWSWIRE

    InDex Beings Enrollment in phase III study of cobitolimod in ulcerative colitis

    24 Nov 2021 //

    PRNEWSWIRE

    InDex Pharmaceuticals strengthens the clinical development organization

    23 Aug 2021 //

    PRNEWSWIRE

    InDex Pharma results of phase IIb study with cobitolimod Published in Lancet

    06 Oct 2020 //

    PRNEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.